Hologic, Inc. logo
Hologic, Inc. (HOLX)
Compare

Hologic, Inc. (HOLX) EV/FCF Ratio: 17.53x

Is Hologic, Inc.’s EV/FCF ratio high or low?

Hologic, Inc.'s EV/FCF ratio of 17.53x is 16% above its 5-year average of 15.13x, around the middle of its 5-year range (6.92x–25.30x).

The EV/FCF ratio for Hologic, Inc. (HOLX) is 17.53x as of Wednesday, June 10, 2026. It is above its 12-month average by 3.79% (16.89x).

HOLX EV/FCF Ratio Chart

HOLX EV/FCF Ratio
17.53x+30.53% 1Y
Zoom

HOLX Average EV/FCF Ratio Chart

HOLX Current vs Average EV/FCF Ratio Chart

HOLX EV/FCF Ratio Metrics

EV/FCF RATIO

17.53x

EV/FCF RATIO AVG TTM

16.89x

EV/FCF RATIO AVG 3Y

18.61x

EV/FCF RATIO AVG 5Y

15.13x

EV/FCF RATIO AVG 10Y

19.80x

EV/FCF RATIO AVG 15Y

21.06x

EV/FCF RATIO AVG 20Y

35.47x

CURRENT VS TTM AVG

+3.79%

CURRENT VS 3Y AVG

-5.82%

CURRENT VS 5Y AVG

+15.89%

CURRENT VS 10Y AVG

-11.47%

CURRENT VS 15Y AVG

-16.78%

CURRENT VS 20Y AVG

-50.58%

HOLX Competitors' EV/FCF Ratio

NAMEMARKET CAPEV/FCF RATIOTTM3Y5Y
Hologic, Inc. (HOLX)17.53x16.89x18.61x15.13x
Moderna, Inc. (MRNA)$18.40BN/A26.90x26.23x26.23x
Align Technology, Inc. (ALGN)$12.56B16.92x17.72x29.59x38.96x
BioNTech SE (BNTX)$21.81B7.13x22.05x6.21x11.27x
Mettler-Toledo International Inc. (MTD)$22.85B31.65x33.77x33.51x38.38x
Waters Corporation (WAT)$23.83B133.18x43.36x43.04x41.43x
Charles River Laboratories International, Inc. (CRL)$9.06B30.84x21.24x29.09x35.23x
Bio-Rad Laboratories, Inc. (BIO)$7.89B24.48x25.09x43.47x51.10x
Veeva Systems Inc. (VEEV)$26.73B48.97x29.32x32.91x38.27x
Hims & Hers Health, Inc. (HIMS)$6.42B98.69x83.00x71.55x71.55x

Cash Flow Valuation Comparison

EV/FCF

17.5x

P/FCF

17.2x

FCF Yield

5.82%

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

  • EV/FCF accounts for debt and cash through enterprise value
  • P/FCF only considers equity value
  • EV/FCF can be compared across companies with different debt levels
  • Both measure how the market values cash generation

Hologic, Inc. EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Hologic, Inc. EV/FCF Ratio FAQ

What is the EV/FCF ratio for Hologic, Inc. (HOLX)?
The EV/FCF ratio for HOLX stock is 17.53x.
Is Hologic, Inc.'s EV/FCF ratio high or low?
Hologic, Inc.'s EV/FCF ratio of 17.53x is 16% above its 5-year average of 15.13x, around the middle of its 5-year range (6.92x–25.30x).
What is the TTM average EV/FCF ratio for Hologic, Inc. (HOLX)?
The TTM average EV/FCF ratio for HOLX stock is 16.89x.
What is the 3Y average EV/FCF ratio for Hologic, Inc. (HOLX)?
The 3Y average EV/FCF ratio for HOLX stock is 18.61x.
What is the 5Y average EV/FCF ratio for Hologic, Inc. (HOLX)?
The 5Y average EV/FCF ratio for HOLX stock is 15.13x.
What is the 10Y average EV/FCF ratio for Hologic, Inc. (HOLX)?
The 10Y average EV/FCF ratio for HOLX stock is 19.80x.
What is the 15Y average EV/FCF ratio for Hologic, Inc. (HOLX)?
The 15Y average EV/FCF ratio for HOLX stock is 21.06x.
What is the 20Y average EV/FCF ratio for Hologic, Inc. (HOLX)?
The 20Y average EV/FCF ratio for HOLX stock is 35.47x.

Hologic, Inc. EV/FCF Ratio History

DATEEV/FCF RATIO
2026-04-0717.53x
2026-04-0617.53x
2026-04-0217.45x
2026-04-0117.44x
2026-03-3117.43x
2026-03-3017.42x
2026-03-2717.45x
2026-03-2617.46x
2026-03-2517.42x
2026-03-2417.42x
2026-03-2317.44x
2026-03-2017.39x
2026-03-1917.37x
2026-03-1817.33x
2026-03-1717.31x
2026-03-1617.33x
2026-03-1317.33x
2026-03-1217.35x
2026-03-1117.39x
2026-03-1017.42x
2026-03-0917.43x
2026-03-0617.47x
2026-03-0517.47x
2026-03-0417.45x
2026-03-0317.40x
2026-03-0217.40x
2026-02-2717.38x
2026-02-2617.35x
2026-02-2517.38x
2026-02-2417.38x
2026-02-2317.40x
2026-02-2017.40x
2026-02-1917.33x
2026-02-1817.35x
2026-02-1717.33x
2026-02-1317.31x
2026-02-1217.28x
2026-02-1117.32x
2026-02-1017.33x
2026-02-0917.30x
2026-02-0617.26x
2026-02-0517.23x
2026-02-0417.21x
2026-02-0317.22x
2026-02-0217.24x
2026-01-3017.28x
2026-01-2917.30x
2026-01-2819.01x
2026-01-2719.04x
2026-01-2619.04x
2026-01-2319.00x
2026-01-2219.02x
2026-01-2119.02x
2026-01-2019.02x
2026-01-1618.98x
2026-01-1518.99x
2026-01-1419.03x
2026-01-1318.96x
2026-01-1218.95x
2026-01-0918.96x
2026-01-0818.96x
2026-01-0718.98x
2026-01-0618.97x
2026-01-0518.93x
2026-01-0218.88x
2025-12-3118.86x
2025-12-3018.88x
2025-12-2918.87x
2025-12-2618.87x
2025-12-2418.87x
2025-12-2318.96x
2025-12-2218.97x
2025-12-1918.98x
2025-12-1818.97x
2025-12-1718.97x
2025-12-1618.99x
2025-12-1519.04x
2025-12-1218.99x
2025-12-1118.95x
2025-12-1018.95x
2025-12-0918.96x
2025-12-0818.95x
2025-12-0518.98x
2025-12-0418.95x
2025-12-0318.99x
2025-12-0218.95x
2025-12-0118.95x
2025-11-2818.98x
2025-11-2618.94x
2025-11-2518.96x
2025-11-2418.93x
2025-11-2118.83x
2025-11-2018.77x
2025-11-1918.79x
2025-11-1818.77x
2025-11-1718.65x
2025-11-1418.65x
2025-11-1318.67x
2025-11-1218.75x
2025-11-1118.76x
2025-11-1018.68x
2025-11-0718.64x
2025-11-0618.65x
2025-11-0518.67x
2025-11-0418.64x
2025-11-0318.63x
2025-10-3118.59x
2025-10-3018.60x
2025-10-2918.61x
2025-10-2818.61x
2025-10-2718.60x
2025-10-2418.61x
2025-10-2318.59x
2025-10-2218.60x
2025-10-2118.61x
2025-10-2018.10x
2025-10-1717.62x
2025-10-1617.29x
2025-10-1516.93x
2025-10-1416.67x
2025-10-1316.57x
2025-10-1017.11x
2025-10-0917.32x
2025-10-0817.25x
2025-10-0717.11x
2025-10-0617.01x
2025-10-0317.22x
2025-10-0217.15x
2025-10-0116.94x
2025-09-3017.05x
2025-09-2916.97x
2025-09-2616.98x
2025-09-2516.64x
2025-09-2416.79x
2025-09-2317.08x
2025-09-2217.00x
2025-09-1916.77x
2025-09-1817.24x
2025-09-1717.22x
2025-09-1616.05x
2025-09-1516.16x
2025-09-1216.32x
2025-09-1116.78x
2025-09-1016.57x
2025-09-0916.86x
2025-09-0816.82x
2025-09-0516.87x
2025-09-0416.78x
2025-09-0316.75x
2025-09-0216.84x
2025-08-2916.96x
2025-08-2816.84x
2025-08-2716.87x
2025-08-2616.84x
2025-08-2516.96x
2025-08-2217.23x
2025-08-2116.97x
2025-08-2017.35x
2025-08-1917.13x
2025-08-1817.00x
2025-08-1517.13x
2025-08-1417.19x
2025-08-1317.41x
2025-08-1217.16x
2025-08-1117.17x
2025-08-0817.19x
2025-08-0717.15x
2025-08-0616.90x
2025-08-0517.13x
2025-08-0417.15x
2025-08-0116.97x
2025-07-3116.89x
2025-07-3016.09x
2025-07-2916.34x
2025-07-2816.26x
2025-07-2516.44x
2025-07-2416.35x
2025-07-2316.32x
2025-07-2216.18x
2025-07-2115.80x
2025-07-1815.86x
2025-07-1715.87x
2025-07-1615.83x
2025-07-1515.70x
2025-07-1416.01x
2025-07-1116.26x
2025-07-1016.52x
2025-07-0916.29x
2025-07-0816.07x
2025-07-0715.95x
2025-07-0316.05x
2025-07-0216.17x
2025-07-0116.17x
2025-06-3016.13x
2025-06-2716.10x
2025-06-2616.12x
2025-06-2515.93x
2025-06-2416.06x
2025-06-2315.97x
2025-06-2015.98x
2025-06-1815.86x
2025-06-1715.90x
2025-06-1616.14x
2025-06-1316.04x
2025-06-1216.15x
2025-06-1116.00x
2025-06-1016.13x
2025-06-0916.00x
2025-06-0615.94x
2025-06-0515.65x
2025-06-0415.54x
2025-06-0315.65x
2025-06-0215.41x
2025-05-3015.45x
2025-05-2915.62x
2025-05-2815.80x
2025-05-2715.45x
2025-05-2313.63x
2025-05-2213.67x
2025-05-2113.75x
2025-05-2014.13x
2025-05-1914.12x
2025-05-1614.21x
2025-05-1513.96x
2025-05-1413.88x
2025-05-1314.28x
2025-05-1214.67x
2025-05-0914.20x
2025-05-0814.07x
2025-05-0713.89x
2025-05-0613.36x
2025-05-0513.27x
2025-05-0213.60x
2025-05-0112.60x
2025-04-3012.79x
2025-04-2912.83x
2025-04-2812.77x
2025-04-2512.75x
2025-04-2412.81x
2025-04-2312.78x
2025-04-2212.79x
2025-04-2112.53x
2025-04-1712.66x
2025-04-1612.44x
2025-04-1512.72x
2025-04-1412.93x
2025-04-1112.72x
2025-04-1012.58x
2025-04-0913.02x
2025-04-0812.85x
2025-04-0713.43x
2025-04-0413.35x
2025-04-0313.52x
2025-04-0213.28x
2025-04-0113.45x
2025-03-3113.53x
2025-03-2813.44x
2025-03-2713.65x
2025-03-2613.47x
2025-03-2513.33x

Showing the most recent 260 of 4,681 data points. The chart above shows the full history.

About Hologic, Inc.

Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.

Marlborough, MA
7,063 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Paul Malenchini